MarketCap
Mereo BioPharma Group plc MREO
€ 0.28
3.33%
Facebook
X
Telegram
Mereo BioPharma Group plc ROA | MREO
ROA Jährlich Mereo BioPharma Group plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -259.95 | -40.31 | -47.61 | -40.27 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -40.27 | -259.95 | -97.03 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Maravai LifeSciences Holdings
MRVI
|
-16.97 | $ 7.71 | -1.91 % | $ 1.11 B |  USA |
 |
Lexicon Pharmaceuticals
LXRX
|
-27.21 | $ 1.86 | 1.34 % | $ 675 M | USA |
 |
Moleculin Biotech
MBRX
|
-151.68 | $ 8.05 | -0.12 % | $ 9.54 M | USA |
 |
Nurix Therapeutics
NRIX
|
-38.43 | $ 16.46 | 3.65 % | $ 1.43 B | USA |
 |
Nkarta
NKTX
|
-25.75 | $ 1.49 | 10.0 % | $ 110 M | USA |
 |
MacroGenics
MGNX
|
-0.03 | $ 2.33 | -3.85 % | $ 147 M | USA |
 |
Protagonist Therapeutics
PTGX
|
-19.48 | $ 134.78 | -1.06 % | $ 8.57 B | USA |
 |
Nuvation Bio
NUVB
|
-34.4 | $ 4.3 | 2.26 % | $ 1.47 B | USA |
 |
Novo Nordisk A/S
NVO
|
18.87 | $ 41.06 | 0.88 % | $ 182 B |  Danmark |
 |
Marker Therapeutics
MRKR
|
-63.78 | $ 0.95 | 0.07 % | $ 14.5 M | USA |
 |
NextCure
NXTC
|
-65.84 | $ 6.3 | 5.35 % | $ 33.5 M | USA |
 |
Rocket Pharmaceuticals
RCKT
|
-67.52 | $ 2.47 | 0.82 % | $ 274 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
-66.7 | $ 1.25 | 2.87 % | $ 65.7 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
-30.45 | $ 8.16 | 12.24 % | $ 710 M | USA |
 |
Kymera Therapeutics
KYMR
|
17.86 | $ 135.02 | -1.19 % | $ 11.4 B | USA |
 |
Oragenics
OGEN
|
-9.78 | $ 0.35 | 1.4 % | $ 755 K | USA |
 |
Ovid Therapeutics
OVID
|
-11.53 | $ 2.77 | -1.07 % | $ 361 M | USA |
 |
Passage Bio
PASG
|
-31.07 | $ 3.91 | 3.44 % | $ 12.5 M | USA |
 |
Vaxcyte
PCVX
|
-0.03 | $ 68.44 | 3.13 % | $ 9.31 B | USA |
 |
Relay Therapeutics
RLAY
|
-44.5 | $ 19.87 | -0.35 % | $ 3.41 B | USA |
 |
Precigen
PGEN
|
-161.15 | $ 4.75 | 4.98 % | $ 1.49 B | USA |
 |
Avidity Biosciences
RNA
|
-34.96 | $ 7.97 | -3.22 % | $ 1.1 B | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
-40.48 | $ 0.81 | -0.07 % | $ 4.85 M | USA |
 |
Spero Therapeutics
SPRO
|
12.44 | $ 1.02 | 1.49 % | $ 57.1 M | USA |
 |
Praxis Precision Medicines
PRAX
|
-32.31 | $ 346.47 | 2.63 % | $ 7.8 B | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
-70.41 | $ 3.8 | 1.06 % | $ 292 M | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
-37.41 | $ 1.26 | -3.82 % | $ 133 M |  Niderland |
 |
Ocular Therapeutix
OCUL
|
-32.91 | $ 6.66 | 0.68 % | $ 1.25 B | USA |
 |
PolyPid Ltd.
PYPD
|
-153.18 | $ 6.56 | 3.96 % | $ 107 M |  Israel |
 |
Outlook Therapeutics
OTLK
|
-335.9 | $ 0.48 | 4.34 % | $ 16.7 M | USA |
 |
uniQure N.V.
QURE
|
-24.12 | $ 24.64 | 8.5 % | $ 1.42 B | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
-37.53 | $ 16.7 | 3.44 % | $ 1.65 B | USA |
 |
Sarepta Therapeutics
SRPT
|
-21.3 | $ 16.67 | 1.4 % | $ 1.67 B | USA |
 |
Rafael Holdings
RFL
|
-35.68 | $ 1.12 | 4.67 % | $ 57.6 M | USA |
 |
REGENXBIO
RGNX
|
-42.8 | $ 8.57 | 11.38 % | $ 442 M | USA |
 |
Rigel Pharmaceuticals
RIGL
|
71.46 | $ 44.17 | 0.58 % | $ 794 M | USA |
 |
SELLAS Life Sciences Group
SLS
|
-34.29 | $ 8.41 | 0.5 % | $ 917 M | USA |
 |
Celsion Corporation
CLSN
|
117.96 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
-56.09 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
-50.47 | $ 1.7 | 0.3 % | $ 66.7 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.0 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-142.36 | - | -13.47 % | $ 169 M | France |
 |
CureVac N.V.
CVAC
|
20.2 | - | - | $ 867 M |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M | Israel |
 |
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B |  Britain |
|
Rezolute
RZLT
|
-68.75 | $ 4.09 | 1.74 % | $ 425 M | USA |
 |
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | Britain |